<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38443459</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Occult endocrine disorders newly diagnosed in patients with post-COVID-19 symptoms.</ArticleTitle><Pagination><StartPage>5446</StartPage><MedlinePgn>5446</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5446</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-55526-3</ELocationID><Abstract><AbstractText>Determination of long COVID requires ruling out alternative diagnoses, but there has been no report on the features of alternative diagnoses. This study was a single-center retrospective study of outpatients who visited our clinic between February 2021 and June 2023 that was carried out to determine the characteristics of alternative diagnoses in patients with post-COVID-19 symptoms. In a total of 731 patients, 50 patients (6.8%) were newly diagnosed with 52 diseases requiring medical intervention, and 16 (32%) of those 50 patients (2.2% of the total) were considered to have priority for treatment of the newly diagnosed disorders over long COVID treatment. The proportion of patients with a new diagnosis increased with advance of age, with 15.7% of the patients aged 60&#xa0;years or older having a new diagnosis. Endocrine and metabolic diseases and hematological and respiratory diseases were the most common, being detected in eight patients (16%) each. Although 35 of the 52 diseases (67%) were related to their symptoms, endocrine and metabolic diseases were the least associated with specific symptoms. Other disorders that require attention were found especially in elderly patients with symptomatic long COVID. Thus, appropriate assessment and differentiation from alternative diagnoses are necessary for managing long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan. y-nakano@okayama-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunada</LastName><ForeName>Naruhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumasu</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurada</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Yui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omura</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochi</LastName><ForeName>Kanako</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasuda</LastName><ForeName>Miho</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiya</LastName><ForeName>Hideharu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueda</LastName><ForeName>Keigo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004700" MajorTopicYN="Y">Endocrine System Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008659" MajorTopicYN="Y">Metabolic Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Endocrine disorders</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Metabolic disorders</Keyword><Keyword MajorTopicYN="N">Thyroid disease</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>6</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>5</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38443459</ArticleId><ArticleId IdType="pmc">PMC10914791</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-55526-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-55526-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering, A. V., van Zon, S. K. R., Olde Hartman, T. C., Rosmalen, J. G. M. &amp; Lifelines Corona Research, I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet400, 452&#x2013;461. 10.1016/S0140-6736(22)01214-4 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum. 2022;3:e221809. doi: 10.1001/jamahealthforum.2022.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y, et al. Clinical characteristics of japanese patients who visited a COVID-19 aftercare clinic for post-acute sequelae of COVID-19/Long COVID. Cureus. 2021;13:e18568. doi: 10.7759/cureus.18568.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18568</ArticleId><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick D, et al. COVID-19 induced postural orthostatic tachycardia syndrome (POTS): A review. Cureus. 2023;15:e36955. doi: 10.7759/cureus.36955.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36955</ArticleId><ArticleId IdType="pmc">PMC10065129</ArticleId><ArticleId IdType="pubmed">37009342</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front. Med. (Lausanne) 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K, et al. Clinical characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosed in patients with long COVID. Medicina (Kaunas) 2022;58:850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit GY, Wang K, Viveiros A, Kellner MJ, Penninger JM. Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic. Cell. 2023;186:906&#x2013;922. doi: 10.1016/j.cell.2023.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.01.039</ArticleId><ArticleId IdType="pmc">PMC9892333</ArticleId><ArticleId IdType="pubmed">36787743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandara T, Deshmukh HA, Abdalla M, Sathyapalan T. Metabolic and endocrine complications of long-COVID-19: A review. Exp. Clin. Endocrinol. Diabetes. 2023;131:367&#x2013;374. doi: 10.1055/a-2063-8697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-2063-8697</ArticleId><ArticleId IdType="pubmed">36977491</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023 doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, Otsuka Y, Honda H, Tokumasu K, Otsuka F. Phase-dependent trends of male hypogonadism in long COVID patients. Endocr. J. 2023;70:755&#x2013;756. doi: 10.1507/endocrj.EJ23-0266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ23-0266</ArticleId><ArticleId IdType="pubmed">37394474</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y, Otsuka F. Possibility of endocrine dysfunction in post coronavirus disease 2019 (COVID-19) condition. Endocr. J. 2022;69:1357. doi: 10.1507/endocrj.EJ22-0459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0459</ArticleId><ArticleId IdType="pubmed">36216578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N, et al. Hormonal trends in patients suffering from long COVID symptoms. Endocr. J. 2022;69:1173&#x2013;1181. doi: 10.1507/endocrj.EJ22-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y, et al. Detection of male hypogonadism in patients with post COVID-19 condition. J. Clin. Med. 2022 doi: 10.3390/jcm11071955.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071955</ArticleId><ArticleId IdType="pmc">PMC8999458</ArticleId><ArticleId IdType="pubmed">35407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid-an update for primary care. BMJ. 2022;378:e072117. doi: 10.1136/bmj-2022-072117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S, Karim M, Gupta V, Goel H, Jain R. A comprehensive review of COVID-19-associated endocrine manifestations. South Med. J. 2023;116:350&#x2013;354. doi: 10.14423/SMJ.0000000000001542.</Citation><ArticleIdList><ArticleId IdType="doi">10.14423/SMJ.0000000000001542</ArticleId><ArticleId IdType="pmc">PMC10044587</ArticleId><ArticleId IdType="pubmed">37011583</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z, et al. Association of COVID-19 infection with incident diabetes. JAMA Netw. Open. 2023;6:e238866. doi: 10.1001/jamanetworkopen.2023.8866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.8866</ArticleId><ArticleId IdType="pmc">PMC10114057</ArticleId><ArticleId IdType="pubmed">37071420</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CT, et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab. 2021;33:1565&#x2013;1576 e1565. doi: 10.1016/j.cmet.2021.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara S, et al. Trends in childhood obesity in Japan: A nationwide observational study from 2012 to 2021. Clin. Obes. 2023 doi: 10.1111/cob.12636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cob.12636</ArticleId><ArticleId IdType="pubmed">38156435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Seo GH, Song K. Beyond acute COVID-19: Investigating the incidence of subacute thyroiditis in long COVID-19 in Korea. Endocrinol. Metab. (Seoul) 2023 doi: 10.3803/EnM.2023.1711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3803/EnM.2023.1711</ArticleId><ArticleId IdType="pmc">PMC10475963</ArticleId><ArticleId IdType="pubmed">37550861</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftah E, et al. Subacute thyroiditis following COVID-19: A systematic review. Front. Endocrinol. (Lausanne) 2023;14:1126637. doi: 10.3389/fendo.2023.1126637.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1126637</ArticleId><ArticleId IdType="pmc">PMC10115182</ArticleId><ArticleId IdType="pubmed">37091856</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancatella A, Viola N, Santini F, Latrofa F. COVID-induced thyroid autoimmunity. Best Pract. Res. Clin. Endocrinol. Metab. 2023;37:101742. doi: 10.1016/j.beem.2023.101742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2023.101742</ArticleId><ArticleId IdType="pubmed">36813660</ArticleId></ArticleIdList></Reference><Reference><Citation>Barajas Galindo DE, et al. Increased incidence of graves' disease during the SARS-CoV2 pandemic. Clin. Endocrinol. (Oxf) 2023;98:730&#x2013;737. doi: 10.1111/cen.14860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14860</ArticleId><ArticleId IdType="pmc">PMC9877771</ArticleId><ArticleId IdType="pubmed">36510647</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi B, et al. COVID-19-induced autoimmune thyroiditis: Exploring molecular mechanisms. J. Med. Virol. 2023;95:e29001. doi: 10.1002/jmv.29001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29001</ArticleId><ArticleId IdType="pubmed">37515444</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y, et al. Utility of serum ferritin for predicting myalgic encephalomyelitis/chronic fatigue syndrome in patients with long COVID. J. Clin. Med. 2023;12:4737. doi: 10.3390/jcm12144737.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12144737</ArticleId><ArticleId IdType="pmc">PMC10381392</ArticleId><ArticleId IdType="pubmed">37510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiya H, et al. Relevance of complement immunity with brain fog in patients with long COVID. J. Infect. Chemother. 2024;30:236&#x2013;241. doi: 10.1016/j.jiac.2023.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2023.10.016</ArticleId><ArticleId IdType="pubmed">37866620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurada Y, et al. Clinical characteristics of female long COVID patients with menstrual symptoms: A retrospective study from a Japanese outpatient clinic. J. Psychosom. Obstet. Gynaecol. 2024;45:2305899. doi: 10.1080/0167482X.2024.2305899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0167482X.2024.2305899</ArticleId><ArticleId IdType="pubmed">38270210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato Y. Case management of COVID-19 (secondary version) JMA J. 2021;4:191&#x2013;197. doi: 10.31662/jmaj.2021-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.31662/jmaj.2021-0036</ArticleId><ArticleId IdType="pmc">PMC8355701</ArticleId><ArticleId IdType="pubmed">34414312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transpl. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>